GlobalData on MSN14h
FDA grants ODD status to Zai Lab’s lung cancer treatment
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).
Zai Lab Gets FDA Orphan Drug Designation For ZL-1310 To Treat Small Cell Lung Cancer
Zai Lab Limited (ZLAB) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation or ODD to ZL-1310, a ...
Why Is Andreas Halvorsen Bullish On Zai Lab Limited (ZLAB) Now?
We recently compiled a list of the Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks. In this article, we are ...
Le Lézard23h
IMCAS 2025: Galderma's Broad Presence and New Data on Recently Launched Products Restylane® SHAYPEtm and Relfydess® Reaffirm Its Category Leadership
Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025 on January 30 ? February 1 in Paris, ...
Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?
We recently published a list of 12 High Growth International Stocks to Invest in Now. In this article, we are going to take a ...
MT Newswires on MSN14h
Asian Equities Traded in the US as American Depositary Receipts Ease in Thursday Trading
Asian equities traded in the US as American depositary receipts were edging lower on Thursday morning, down 0.2% to 2,123.24 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by ...
Is argenx SE (ARGX) the High Growth International Stock to Invest in Now?
We recently published a list of 12 High Growth International Stocks to Invest in Now. In this article, we are going to take a ...
What To Expect From The Stock Market in 2025?
We recently published a list of 12 High Growth International Stocks to Invest in Now. In this article, we are going to take a ...